AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2009
Apr 23, 2009
34105_dirs_2009-04-23_a5501825-b3a5-4597-be49-4f3fb9ef69fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2009-04-23
Reporting Person: Comerford Peter F (VP of Admin. & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-04-23 | Common Stock, $.10 par value | M | 15000 | $4.96 | Acquired | 48830 | Direct |
| 2009-04-23 | Common Stock, $.10 par value | F | 11489 | $7.97 | Disposed | 37341 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-04-23 | Common Stock (Right to Buy) | $4.96 | M | 15000 | Disposed | 2009-04-25 | Common Stock; $.10 par value (15000) | Direct |
Footnotes
F1: This represents the total number of shares acquired prior to the cashless exercise of 15,000 shares.
F2: The shares were sold to the issuer and were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.96.
More from ULTRALIFE CORP
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 16